A newer group of NSAIDs, which are sometimes called "superaspirins" because they can be given in higher doses than aspirin without causing stomach upset or bleeding
Approximately 15% of NSAID users have gastrointestinal tract symptoms such as dyspepsia, heartburn, nausea or vomiting.
The COX-2 inhibitors include celecoxib (Celebrex), rofecoxib (Vioxx), and valdecoxib (Bextra).
The only Cox-2 inhibitor on the market as of April 2005 is celecoxib (Celebrex).
Yes